Re:23andMe has signed a $300M deal with GlaxoSmithKline
by lakeeffect on Saturday January 05, 2019 @10:38AM
(#18832130)
The article says it's opt-out not opt-in, and purpose is to find drug targets and clinical trail participants.
[ Parent
| on HN ]
There are no comments on this comment yet.